I might give an unsatisfying answer, but the truth is that right now, we are exclusively focused on delivering the highest quality product for our patients.
Another factor keeping companies private is the rise of the secondaries market as an increasingly common way to give investors and employees some liquidity.
Ro has raised more than $1 billion in venture capital from the likes of General Catalyst, Initialized Capital and Torch Capital, among many others.
Ro was founded in 2017 as a telehealth company focused on erectile dysfunction, but has now become well known for multiple GLP-1 options.
Collection
[
|
...
]